Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
314.50M | 261.28M | 209.39M | 151.31M | 117.01M | Gross Profit |
141.56M | 108.67M | 76.10M | 58.27M | 50.20M | EBIT |
61.14M | 32.96M | 8.29M | -64.40M | -36.14M | EBITDA |
49.81M | 45.83M | 17.01M | 13.55M | 23.09M | Net Income Common Stockholders |
30.43M | 14.14M | 2.63M | 8.30M | 18.75M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
54.28M | 41.96M | 28.74M | 28.53M | 24.91M | Total Assets |
397.65M | 354.89M | 321.35M | 267.80M | 185.84M | Total Debt |
61.07M | 143.22M | 165.16M | 174.96M | 119.04M | Net Debt |
6.79M | 101.26M | 136.42M | 146.44M | 94.13M | Total Liabilities |
358.58M | 338.11M | 354.98M | 336.99M | 224.24M | Stockholders Equity |
43.89M | 56.55M | 10.67M | -14.21M | -4.88M |
Cash Flow | Free Cash Flow | |||
70.56M | 38.60M | 23.11M | 20.04M | 14.28M | Operating Cash Flow |
71.54M | 50.76M | 35.72M | 35.44M | 24.64M | Investing Cash Flow |
-12.42M | -19.18M | -12.57M | -15.38M | -10.33M | Financing Cash Flow |
-45.20M | -17.92M | -23.25M | -15.83M | -3.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $34.03B | 11.52 | 19.58% | 1.66% | 8.19% | 29.77% | |
77 Outperform | $4.97B | 9.27 | 9.91% | ― | -15.68% | -47.11% | |
75 Outperform | $1.10B | 8.21 | 22.41% | 0.35% | 13.29% | 17.14% | |
71 Outperform | $3.49B | 77.71 | 60.58% | ― | 21.60% | 90.80% | |
70 Outperform | $1.84B | 16.75 | 4.63% | 2.42% | -32.79% | -94.89% | |
67 Neutral | $16.87B | 11.23 | 14.28% | 3.93% | 18.02% | 171.70% | |
63 Neutral | $12.33B | 9.59 | 8.02% | 79.26% | 12.87% | -4.61% |
On April 16, 2025, Goosehead Insurance appointed Bill Wade to its Board of Directors. Wade, a former senior partner at Bain & Company with over 25 years of experience, is recognized for his expertise in leveraging AI and emerging technologies to drive innovation and growth. His appointment is seen as a strategic move to bolster Goosehead’s technology-driven expansion in the insurance industry, aiming to enhance client experiences and solidify its leadership position.
Spark’s Take on GSHD Stock
According to Spark, TipRanks’ AI Analyst, GSHD is a Outperform.
GooseHead Insurance presents a solid investment opportunity with strong financial performance and technical momentum. Strategic growth initiatives and technological advancements highlight future potential. However, high valuation metrics and challenges in key markets and client retention pose risks.
To see Spark’s full report on GSHD stock, click here.